New York files charges against Johnson & Johnson on insurance fraud regarding opioid claims

New York state filed civil charges on Thursday accusing Johnson & Johnson of insurance fraud for downplaying the risks of opioid painkillers, including to doctors and elderly patients. J&J and its Janssen Pharmaceuticals affiliate were accused of targeting elderly patients for opioid treatment despite the risks of side effects such as falls, fractures and neuropsychiatric… Read More New York files charges against Johnson & Johnson on insurance fraud regarding opioid claims

Johnson & Johnson set to acquire Momenta Pharmaceuticals in $6.5billion deal

Johnson & Johnson said on Wednesday it would buy Momenta Pharmaceuticals Inc for about $6.5 billion in cash to bolster its portfolio of treatments for autoimmune diseases. Momenta shares were up 68% at $51.98 before the bell, just shy of the offer price of $52.20. The deal gives Johnson & Johnson’s Janssen unit access to… Read More Johnson & Johnson set to acquire Momenta Pharmaceuticals in $6.5billion deal

Oklahoma judge orders Johnson & Johnson to pay $572million in opioid epidemic case

An Oklahoma judge on Monday ordered Johnson & Johnson to pay $572.1 million to the state for its part in fueling an opioid epidemic by deceptively marketing addictive painkillers. J&J said it would to appeal the decision, though the award was below what some investors and analysts had feared, in what had been a $17… Read More Oklahoma judge orders Johnson & Johnson to pay $572million in opioid epidemic case